NCT03631771View on ClinicalTrials.gov

Pediatric Risk of Hypothyroidism With Iodinated Contrast Media

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 31, 2022

Primary Completion Date

August 31, 2024

Study Completion Date

February 28, 2025

Conditions
Hypothyroidism
Interventions
DRUG

Iohexol

Iohexol administered intravascularly

DRUG

Iodixanol

Iodixanol administered intravascularly

DRUG

Iopromide

Iopromide administered intravascularly

DRUG

Ioversol

Ioversol administered intravascularly

Sponsors

Lead Sponsor

GE Healthcare

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

collaborator

Guerbet/Liebel-Flarsheim

UNKNOWN

lead

GE Healthcare

INDUSTRY

NCT03631771 - Pediatric Risk of Hypothyroidism With Iodinated Contrast Media | Biotech Hunter | Biotech Hunter